Items where Author is "Fritsch, K."
Jump to: Yes Number of items: 5. YesKasenda, B. and Ferreri, A. J. M. and Marturano, E. and Forst, D. and Bromberg, J. and Ghesquieres, H. and Ferlay, C. and Blay, J. Y. and Hoang-Xuan, K. and Pulczynski, E. J. and Fosså, A. and Okoshi, Y. and Chiba, S. and Fritsch, K. and Omuro, A. and O'Neill, B. P. and Bairey, O. and Schandelmaier, S. and Gloy, V. and Bhatnagar, N. and Haug, S. and Rahner, S. and Batchelor, T. T. and Illerhaus, G. and Briel, M.. (2015) First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL) - a systematic review and individual patient data meta-analysis. Annals of Oncology, 26 (7). pp. 1305-1313. O'Neill, A. and Mikesch, K. and Fritsch, K. and Kasenda, B. and Banerjee, L. and Burns, F. and Zakout, G. and Johnston, R. and Illerhaus, G. and Cwynarski, K.. (2015) Outcomes for HIV-positive patients with primary central nervous system lymphoma after high-dose chemotherapy and auto-SCT. Bone Marrow Transplantation, 50 (7). pp. 999-1000. Kasenda, B. and Schorb, E. and Fritsch, K. and Finke, J. and Illerhaus, G.. (2015) Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma - a long-term follow-up study. Annals of Oncology, 26 (3). pp. 608-611. Kasenda, B. and Schorb, E. and Fritsch, K. and Finke, J. and Illerhaus, G.. (2012) Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study. Annals of Oncology, 23 (10). pp. 2670-2675. Fritsch, K. and Kasenda, B. and Hader, C. and Nikkhah, G. and Prinz, M. and Haug, V. and Haug, S. and Ihorst, G. and Finke, J. and Illerhaus, G.. (2011) Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly. Annals of Oncology, 22 (9). pp. 2080-2085. |
